Oncology

MercyOne's specialty clinic in Des Moines is ending gynecologic oncology surgical services June 1, ABC affiliate KCCI reported April 23.

The FDA has approved a first-in-class bladder cancer drug.

Physicians prescribe 5% more cancer drugs following a pharmaceutical representitive's visit, but the practice does not appear to affect cancer patients' mortality, NPR reported April 22.

University of Pittsburgh Medical Center researchers found a way to predict when a rare eye cancer will respond to treatment, The Washington Post reported April 22.

The National Cancer Institute recognized Philadelphia-based Jefferson Health's Sidney Kimmel Cancer Center as a comprehensive cancer center.

The implementation of IT solutions that pull physicians away from patients and moving profits to payer groups are two issues that concern John Montville, executive director of the oncology service line at Mercy Health-Lourdes Hospital in Paducah, Ky.

Bin Zheng, PhD, who specializes in targeted therapies and immunotherapy, was appointed director of melanoma research in the Department of Biomedical Sciences at Los Angeles-based Cedars-Sinai Cancer.

A growing body of research shows cancer rates are on the rise in adults younger than 50. In response, many oncologists have pointed to the need for more awareness across the healthcare continuum, stronger care coordination on the primary care…

Houston-based University of Texas MD Anderson Cancer Center has partnered with CureVac, a global biopharmaceutical company, to develop novel mRNA-based cancer vaccines.

Medicare reimbursement for common breast cancer surgeries have declined significantly over the last 20 years, a new study from researchers at the Fox Chase Cancer Center and Temple University Hospital, both based in Philadelphia, found.